Line 1: |
Line 1: |
− | '''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and others with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' | + | '''Welcome to the Compendium of Cancer Genome Aberrations (CCGA)! The CCGA is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification. The Wiki style interface allows for real-time editing and content sharing within our genetics community. This resource is sponsored and supported by the [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>] and contributed to by colleagues with an interest in clinical cytogenetics, molecular genetics and genomics in cancer.''' |
| | | |
| *Join the CCGA community! If you would like to contribute as an author, please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. | | *Join the CCGA community! If you would like to contribute as an author, please complete a few brief questions on our '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. |
| | | |
− | *'''[Mailto:CCGA@cancergenomics.org|Contact <u>Contact us</u>]''' for more information or suggestions for updates. | + | *'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' for more information or suggestions for updates. |
| | | |
− | *Meet our editorial '''<u>[[Leadership]]</u>'''. | + | *Meet our '''<u>[[Leadership|Editorial Leadership]]</u>''', '''<u>[[CCGA Workgroup|CCGA Workgroup Members]]</u>''' and [[Communications Liaison|<u>'''Communications Liaison'''</u>]]. |
| | | |
| *For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''. | | *For contributors, we've created a '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' demonstrating how to add content to the CCGA. Please also refer to helpful '''<u>[[Author Instructions|Author Instructions]]</u>'''. |
| + | *Become a part of our Twitter family for the latest updates [https://twitter.com/ccgawiki '''@ccgawiki''']. |
| | | |
| {{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''. | | {{Box-round|title=Newest Items|titlebackground=#06B5AD|Explore the great content available in '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', '''<u>[[Myelodysplastic Syndromes (MDS)|Myelodysplastic Syndromes (MDS)]]</u>''', '''<u>[[Myeloproliferative Neoplasms (MPN)|Myeloproliferative Neoplasms (MPN)]]</u>''', and '''<u>[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)]]</u>'''. |
| }} | | }} |
− | <br /> | + | <br /> |
| <inputbox> | | <inputbox> |
| type=search2 | | type=search2 |
Line 17: |
Line 18: |
| placeholder=enter search term | | placeholder=enter search term |
| </inputbox> | | </inputbox> |
− | [[File:Generic book cover heme and lymphoid.jpg|thumb|link=Tumours of Haematopoietic and Lymphoid Tissues|Search content structured based on the WHO Classification ('''click book image'''). ''Reference: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. IARC Press: Lyon, France, 2017.'']] | + | [[File:Generic book cover heme and lymphoid.jpg|thumb|link=Tumours of Haematopoietic and Lymphoid Tissues|Search content structured based on the WHO Classification ('''click book image'''). ''Reference: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, Revised 4th edition. IARC Press: Lyon, France, 2017. The hierarchical tumour classification structure is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer.'']] |
| | | |
| | | |
Line 43: |
Line 44: |
| <br /><br /><br /> | | <br /><br /><br /> |
| [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[Pediatric]] | | [[File:Circos.png|100px|link=Main_Page]] '''Cancer Genomes''' [[Hematologic and Lymphoid]] | [[Solid Tumors]] | [[CNS]] | [[Pediatric]] |
| + | <br> |
| + | <br> |
| + | [[File:CGC logo only.png|100px|link=Main_Page]]<span id="fp-span-cgc-pre"> '''CGC Workgroups Recurrent Loci Tables'''</span><span id="fp-span-cgc" style="display: block; margin-top: -62px; margin-left: 385px;"> [[AML Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|AML]] | [[MDS, MDS/MPN and MPN Tables: Recurrent Genomic Alterations Detected by Chromosomal Microarray|MDS/MPN]] | [[CLL Tables: Regions of Recurrent Copy Number Change and CN-LOH|CLL]] | [[Recurrent Genomic Alterations in Pediatric and Adult Central Nervous System Tumors Detected by Chromosomal Microarray|CNS Tumors]] | [[Plasma Cell Neoplasms Tables: Recurrent Cytogenomic Alterations|Plasma Cell Neoplasms]] | [[Breast Cancer Table: Recurrent Genomic Alterations Detected by Chromosomal Microarray|Breast Cancer]] | [[Renal Cell Neoplasia Tables: Recurrent Cytogenomic Alterations|Renal Neoplasia]] | [[B-ALL Tables: Prognostic Genomic Abnormalities and Recurrent Gene Fusions|B-ALL]]</span> |
| <br> | | <br> |
| <br> | | <br> |
| <br> | | <br> |
| <div style="clear: both;"></div> | | <div style="clear: both;"></div> |
− | <div style="margin: auto;"> | + | <div id="bottom-fp-links" style="margin: auto;"> |
| <div style="height:150px;"> | | <div style="height:150px;"> |
− | <div style="width: 25%; float: left;"> | + | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> |
| <div style="float: left; padding-right: 10px; height: 150px;"> | | <div style="float: left; padding-right: 10px; height: 150px;"> |
| [[File:Plus2.png|30px|link=About]] | | [[File:Plus2.png|30px|link=About]] |
Line 62: |
Line 66: |
| </div> | | </div> |
| </div> | | </div> |
− | <div style="width: 25%; float: left;"> | + | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> |
| <div style="float: left; padding-right: 10px; height: 150px;"> | | <div style="float: left; padding-right: 10px; height: 150px;"> |
| [[File:Star.png|45px|link=About]] | | [[File:Star.png|45px|link=About]] |
Line 78: |
Line 82: |
| </div> | | </div> |
| </div> | | </div> |
− | <div style="width: 25%; float: left;"> | + | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> |
| <div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;"> | | <div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;"> |
| [[File:Arrow.png|30px|link=About]] | | [[File:Arrow.png|30px|link=About]] |
Line 85: |
Line 89: |
| <h4>[[Join Us!]]</h4> | | <h4>[[Join Us!]]</h4> |
| [[Request Membership]] | | [[Request Membership]] |
| + | |
| + | </div> |
| + | </div> |
| + | <div class="bottom-fp-links-column" style="width: 24%; float: left;"> |
| + | <div style="float: left; padding-left: 10px; padding-right: 20px; height: 150px;"> |
| + | [[File:Ask.png|30px|link=About]] |
| + | </div> |
| + | <div> |
| + | <h4>[[Frequently Asked Questions (FAQs)|FAQ]]</h4> |
| + | [[Frequently Asked Questions (FAQs)|Frequently Asked Questions]] |
| | | |
| </div> | | </div> |